A Study of an Oral Nutrition Supplement (ONS) in Children.

Inclusion criteria

• Age of 24-72 months (inclusive), both genders.
• Diagnosed with current acute upper respiratory tract infection.
• Weight-for-age between 3rd - 15th percentile according to WHO Growth Charts.
• Identified as a picky eater.
• Able to consume foods and beverages orally.
• Willing to abstain from additional non-study provided protein supplements or nutritional supplements throughout the study period.

Exclusion criteria

• Current illness requiring hospitalization.
• Gastrointestinal infection and/or acute diarrhea at the time of inclusion in the study.
• Currently taking medication that could affect absorption/metabolism of study product or weight of the child.
• Diagnosed with recurrent respiratory infections due to cystic fibrosis, immunodeficiency syndromes, and congenital abnormalities of the respiratory tract, congenital lung and ciliary abnormalities, an unsuspected foreign body and asthma.
• Active tuberculosis, acute hepatitis B or C, or HIV, malignancy.
• History of diabetes mellitus.
• Received antibiotic therapy within the last two weeks before start of the study.
• Dysphagia, aspiration risk, difficulty in swallowing due to acquired / congenital abnormalities that would hamper oral intake of the study product.
• Clinically significant nutritional deficiency requiring specific treatment with any other nutritional supplement (not study product).